These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24174904)

  • 1. Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.
    Bustillo JR
    Dialogues Clin Neurosci; 2013 Sep; 15(3):329-37. PubMed ID: 24174904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR spectroscopic studies of the brain in psychiatric disorders.
    Maddock RJ; Buonocore MH
    Curr Top Behav Neurosci; 2012; 11():199-251. PubMed ID: 22294088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the metabolic alterations in a depressive-like rat model of chronic forced swim stress: An in vivo proton magnetic resonance spectroscopy study at 7T.
    Yoo CH; Lim SI; Song KH; Woo DC; Choe BY
    Neurochem Int; 2018 Jun; 116():22-29. PubMed ID: 29530754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
    Abbott C; Bustillo J
    Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders.
    Xu H; Zhang H; Zhang J; Huang Q; Shen Z; Wu R
    Neurosci Biobehav Rev; 2016 Dec; 71():563-577. PubMed ID: 27702600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
    Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
    Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Yildiz-Yesiloglu A; Ankerst DP
    Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
    Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C
    JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia.
    Dwyer GE; Hugdahl K; Specht K; Grüner R
    Curr Top Med Chem; 2018; 18(21):1908-1924. PubMed ID: 30499397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
    Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
    Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
    Block W; Träber F; von Widdern O; Metten M; Schild H; Maier W; Zobel A; Jessen F
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):415-22. PubMed ID: 18845018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.
    Dobberthien BJ; Tessier AG; Yahya A
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29105187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.
    Szulc A; Wiedlocha M; Waszkiewicz N; Galińska-Skok B; Marcinowicz P; Gierus J; Mosiolek A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():1-8. PubMed ID: 29414126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls.
    Arcos-Burgos M; Londoño AC; Pineda DA; Lopera F; Palacio JD; Arbelaez A; Acosta MT; Vélez JI; Castellanos FX; Muenke M
    Atten Defic Hyperact Disord; 2012 Dec; 4(4):205-12. PubMed ID: 23012086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.
    Fayed N; Garcia-Campayo J; Magallón R; Andrés-Bergareche H; Luciano JV; Andres E; Beltrán J
    Arthritis Res Ther; 2010; 12(4):R134. PubMed ID: 20609227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.
    Hermens DF; Naismith SL; Chitty KM; Lee RS; Tickell A; Duffy SL; Paquola C; White D; Hickie IB; Lagopoulos J
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):836-45. PubMed ID: 25795519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.